4th Conference: Clostridia: from old diseases to new threats - basic science meets infectious diseases
Sunday, 5 October 2008
Opening lecture at 18:30
The discovery of Clostridium and its clinical impact. An insight in the history of medicine
Roland Koerner, Sunderland, UK
Monday, 6 October 2008
Clostridiain in general, their toxins and other pathogenicity factors
Basis of the mode of action of clostridial toxins
Michel-Robert Popoff, Institut Pasteur, Paris, F
Insights into the mechanism of botulinum neurotoxin (BoNT) receptor binding and substrate cleavage from a structural perspective
Axel T. Brunger, Howard Hughes Medical Institute, Stanford, USA
C. perfringens epsilon-toxin
Juan Blasi, Barcelona, ES
Comparative genomics of clostridia and pathogenic properties
Holger Brüggemann, Berlin, DE
Tuesday, 7 October 2008
C. difficile
Clostridium difficile: an overview of the changes in our understanding the organism over the last 30 years<
Maja Rupnik, Institute of Public Health, Maribor, Slovenia
C. difficile - the wider perspective (humans, animals, environment)
Viveca Baverud, Uppsala, SE
Clostridium difficile: an overview of the disease, host defences, risk factors and changing host susceptibility
Ian R. Poxton, Centre for Infectious Diseases, Edinburgh, UK
Clinical spectrum of Clostridium difficile Infection (CDI) and the emergence of hypervirulent strains
Ed J. Kuijper, Centre for Infectious Diseases, Leiden, NL
Wednesday, 8 October 2008
Clostridia: clinical issues
Clostridial infections in the immunocompromised host
David Dockrell, Royal Hallamshire Hospital, Sheffield, UK
Emerging clostridial infections in USA
L. Clifford McDonald, Atlanta, USA
Clostridia in cancer therapy
Jan Theys, Maastricht, NL
Toll-like receptors and intestinal inflammation
William F. Stenson, St-Louis, USA
Thursday, 9 October 2008
Bus leaving to the airport at 8:00 a.m.
Afternoons are dedicated to oral presentations and posters
(see under abstracts & lectures)
